We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Inogen
INGN
$178M
| $3.93M | 0.01% |
57,504
+3,834
| +7% | +$240K |
|
1402
Carvana
CVNA
$76.4B
| $3.92M | 0.01% |
212,875
+5,760
| +3% | +$96.4K |
|
1403
Supernus Pharmaceuticals
SUPN
$2.73B
| $3.92M | 0.01% |
165,038
+10,716
| +7% | +$260K |
|
1404
M/I Homes
MHO
$3.81B
| $3.9M | 0.01% |
99,224
+5,698
| +6% | +$238K |
|
|
ARGO
1405
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $3.9M | 0.01% |
59,378
+1,515
| +3% | +$99.1K |
|
|
CORE
1406
DELISTED
Core Mark Holding Co., Inc.
CORE
| $3.9M | 0.01% |
143,566
+7,925
| +6% | +$219K |
|
|
RAVN
1407
DELISTED
Raven Industries Inc
RAVN
| $3.9M | 0.01% |
113,274
+5,258
| +5% | +$179K |
|
1408
James River Group Holdings
JRVR
$217M
| $3.9M | 0.01% |
94,624
+5,997
| +7% | +$236K |
|
1409
Addus HomeCare
ADUS
$2.17B
| $3.9M | 0.01% |
40,071
+4,527
| +13% | +$399K |
|
1410
QuidelOrtho
QDEL
$1.19B
| $3.89M | 0.01% |
51,885
+1,347
| +3% | +$87K |
|
|
BOLD
1411
DELISTED
Audentes Therapeutics, Inc
BOLD
| $3.89M | 0.01% |
65,035
+3,984
| +7% | +$150K |
|
1412
Heritage Financial
HFWA
$1.23B
| $3.88M | 0.01% |
137,217
+5,943
| +5% | +$164K |
|
|
BIG
1413
DELISTED
Big Lots, Inc.
BIG
| $3.88M | 0.01% |
135,208
+6,523
| +5% | +$151K |
|
1414
Warrior Met Coal
HCC
$4.45B
| $3.88M | 0.01% |
183,475
+14,291
| +8% | +$292K |
|
|
PEGI
1415
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $3.87M | 0.01% |
144,709
+7,300
| +5% | +$198K |
|
|
FOE
1416
DELISTED
Ferro Corporation
FOE
| $3.87M | 0.01% |
260,587
+12,556
| +5% | +$162K |
|
1417
Assured Guaranty
AGO
$3.66B
| $3.86M | 0.01% |
78,673
-337
| -0.4% | -$16.1K |
|
1418
Signet Jewelers
SIG
$3.75B
| $3.85M | 0.01% |
177,265
+9,500
| +6% | +$169K |
|
|
ADSW
1419
DELISTED
Advanced Disposal Services Inc
ADSW
| $3.85M | 0.01% |
116,981
+20,913
| +22% | +$686K |
|
1420
iRhythm Holdings
IRTC
$4.09B
| $3.84M | 0.01% |
56,356
+4,629
| +9% | +$314K |
|
1421
Varex Imaging
VREX
$522M
| $3.84M | 0.01% |
128,707
+5,971
| +5% | +$178K |
|
1422
Patrick Industries
PATK
$2.9B
| $3.84M | 0.01% |
109,749
+4,404
| +4% | +$143K |
|
1423
WSFS Financial
WSFS
$4.23B
| $3.83M | 0.01% |
87,186
+2,457
| +3% | +$107K |
|
1424
Box
BOX
$4.43B
| $3.82M | 0.01% |
227,443
+2,476
| +1% | +$41.5K |
|
1425
Marten Transport
MRTN
$1.22B
| $3.81M | 0.01% |
266,316
+10,149
| +4% | +$145K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.